Ligand validation:9ENJ

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 9ENJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9ENJ_FDA_D_701	46%	65%	0.19	0.926	0.62	0.73	-	2	1	0	100%	1
9ENJ_FDA_A_701	46%	65%	0.194	0.93	0.62	0.73	-	2	1	0	100%	1
9ENJ_FDA_B_701	45%	64%	0.197	0.928	0.61	0.75	-	2	1	0	100%	1
9ENJ_FDA_C_701	41%	65%	0.197	0.914	0.62	0.72	-	2	1	0	100%	1
9ENN_FDA_D_701	80%	63%	0.125	0.976	0.63	0.8	-	1	1	0	100%	1
9ENI_FDA_A_701	49%	64%	0.188	0.936	0.62	0.75	-	2	1	0	100%	1
9ENK_FDA_D_701	44%	64%	0.194	0.923	0.61	0.77	-	2	3	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
3ATR_FDA_A_501	100%	23%	0.039	0.986	1.34	1.81	5	16	1	0	100%	1
4MOF_FDA_A_801	100%	19%	0.04	0.983	1.62	1.84	14	15	1	0	100%	1
7AA2_FDA_B_701	100%	55%	0.044	0.987	0.85	0.89	2	2	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.